<SEC-DOCUMENT>0001641172-25-013165.txt : 20250530
<SEC-HEADER>0001641172-25-013165.hdr.sgml : 20250530
<ACCEPTANCE-DATETIME>20250530215849
ACCESSION NUMBER:		0001641172-25-013165
CONFORMED SUBMISSION TYPE:	3/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250429
FILED AS OF DATE:		20250530
DATE AS OF CHANGE:		20250530

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Tan Kok Hui
		CENTRAL INDEX KEY:			0001512616
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		251012948

	MAIL ADDRESS:	
		STREET 1:		C/O TRUNKBOW INT.HOLDINGS LTD., 12F
		STREET 2:		GEMDALE PLAZA, NO91 JIANGUO RD
		CITY:			CHAOYANG DISTRICT, BEIJING
		STATE:			F4
		ZIP:			100022

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>3/A
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3/A</documentType>

    <periodOfReport>2025-04-29</periodOfReport>

    <dateOfOriginalSubmission>2025-05-14</dateOfOriginalSubmission>

    <noSecuritiesOwned>1</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001130166</issuerCik>
        <issuerName>Cyclacel Pharmaceuticals, Inc.</issuerName>
        <issuerTradingSymbol>CYCC</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001512616</rptOwnerCik>
            <rptOwnerName>Tan Kok Hui</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>LEVEL 10, TOWER 11, AVENUE 5,</rptOwnerStreet1>
            <rptOwnerStreet2>NO. 8, JALAN KERINCHI</rptOwnerStreet2>
            <rptOwnerCity>KUALA LUMPUR,</rptOwnerCity>
            <rptOwnerState>N8</rptOwnerState>
            <rptOwnerZipCode>59200</rptOwnerZipCode>
            <rptOwnerStateDescription>MALAYSIA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>1</isOther>
            <officerTitle></officerTitle>
            <otherText>Shareholder</otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <remarks>This Form 3 amendment is being filed to correct the original Form 3 filed on May 14, 2025 which was filed in error as the Reporting Person is not an officer, director or ten percent owner of the outstanding shares of common stock of Cyclacel Pharmaceuticals, Inc. and therefore not obligated to file a Form 3. The Reporting Person is not voluntarily subjecting itself to Section 16 reporting.</remarks>

    <ownerSignature>
        <signatureName>/s/ Tan Kok Hui</signatureName>
        <signatureDate>2025-05-30</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
